» Articles » PMID: 29390515

Application of Failure Mode and Effect Analysis in Managing Catheter-related Blood Stream Infection in Intensive Care Unit

Overview
Specialty General Medicine
Date 2018 Feb 3
PMID 29390515
Citations 5
Authors
Affiliations
Soon will be listed here.
Abstract

In this study, failure mode and effect analysis (FMEA), a proactive tool, was applied to reduce errors associated with the process which begins with assessment of patient and ends with treatment of complications. The aim of this study is to assess whether FMEA implementation will significantly reduce the incidence of catheter-related bloodstream infections (CRBSIs) in intensive care unit.The FMEA team was constructed. A team of 15 medical staff from different departments were recruited and trained. Their main responsibility was to analyze and score all possible processes of central venous catheterization failures. Failure modes with risk priority number (RPN) ≥100 (top 10 RPN scores) were deemed as high-priority-risks, meaning that they needed immediate corrective action. After modifications were put, the resulting RPN was compared with the previous one. A centralized nursing care system was designed.A total of 25 failure modes were identified. High-priority risks were "Unqualified medical device sterilization" (RPN, 337), "leukopenia, very low immunity" (RPN, 222), and "Poor hand hygiene Basic diseases" (RPN, 160). The corrective measures that we took allowed a decrease in the RPNs, especially for the high-priority risks. The maximum reduction was approximately 80%, as observed for the failure mode "Not creating the maximal barrier for patient." The averaged incidence of CRBSIs was reduced from 5.19% to 1.45%, with 3 months of 0 infection rate.The FMEA can effectively reduce incidence of CRBSIs, improve the security of central venous catheterization technology, decrease overall medical expenses, and improve nursing quality.

Citing Articles

Healthcare Application of Failure Mode and Effect Analysis (FMEA): Is There Room in the Infectious Disease Setting? A Scoping Review.

Vecchia M, Sacchi P, Marvulli L, Ragazzoni L, Muzzi A, Polo L Healthcare (Basel). 2025; 13(1).

PMID: 39791689 PMC: 11719677. DOI: 10.3390/healthcare13010082.


Identification of key risk areas and failure modes using the FMEA method for the prevention and control of major infectious diseases in a stomatology department.

Yang S, Yang L, Chuang Y, Asihaer G, Lin X BMC Oral Health. 2025; 25(1):45.

PMID: 39780161 PMC: 11714806. DOI: 10.1186/s12903-024-05321-3.


Neurocritical Patients: Review of the Scope of Nursing Diagnoses and Care in the Intensive Care Unit.

Peixoto Brito M, Macedo L, de Siqueira Coelho Lisboa K, Dos Santos Sales V, Pinto S, Felix Silva D SAGE Open Nurs. 2023; 9:23779608231158978.

PMID: 36861053 PMC: 9969437. DOI: 10.1177/23779608231158978.


Risk assessment of failure during transitioning from in-centre to home haemodialysis.

Haroon S, Lau T, Tan G, Liu E, Hui S, Lim S BMC Nephrol. 2022; 23(1):406.

PMID: 36539703 PMC: 9768953. DOI: 10.1186/s12882-022-03039-4.


Impact of failure mode and effects analysis-based emergency management on the effectiveness of craniocerebral injury treatment.

Shao X, Wang Y, Chen X, Ding W World J Clin Cases. 2022; 10(2):554-562.

PMID: 35097081 PMC: 8771373. DOI: 10.12998/wjcc.v10.i2.554.


References
1.
Warren D, Yokoe D, Climo M, Herwaldt L, Noskin G, Zuccotti G . Preventing catheter-associated bloodstream infections: a survey of policies for insertion and care of central venous catheters from hospitals in the prevention epicenter program. Infect Control Hosp Epidemiol. 2006; 27(1):8-13. DOI: 10.1086/499151. View

2.
Day S, Dalto J, Fox J, Turpin M . Failure mode and effects analysis as a performance improvement tool in trauma. J Trauma Nurs. 2006; 13(3):111-7. DOI: 10.1097/00043860-200607000-00008. View

3.
Rupp M, Lisco S, Lipsett P, Perl T, Keating K, Civetta J . Effect of a second-generation venous catheter impregnated with chlorhexidine and silver sulfadiazine on central catheter-related infections: a randomized, controlled trial. Ann Intern Med. 2005; 143(8):570-80. DOI: 10.7326/0003-4819-143-8-200510180-00007. View

4.
Lago P, Bizzarri G, Scalzotto F, Parpaiola A, Amigoni A, Putoto G . Use of FMEA analysis to reduce risk of errors in prescribing and administering drugs in paediatric wards: a quality improvement report. BMJ Open. 2012; 2(6). PMC: 3533113. DOI: 10.1136/bmjopen-2012-001249. View

5.
Rosenthal V, Maki D, Jamulitrat S, Medeiros E, Todi S, Gomez D . International Nosocomial Infection Control Consortium (INICC) report, data summary for 2003-2008, issued June 2009. Am J Infect Control. 2010; 38(2):95-104.e2. DOI: 10.1016/j.ajic.2009.12.004. View